These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 738339)

  • 1. Preliminary evaluation of a phase I clinical study of quelamycin.
    Cortés H; Vicente J; Baena L; Otero J; Gosálvez M
    Eur J Cancer (1965); 1978 Dec; 14(12):1359-61. PubMed ID: 738339
    [No Abstract]   [Full Text] [Related]  

  • 2. Early clinical trial with quelamycin.
    Cortés-Funes H; Gosálvez M; Moyano A; Mañas A; Mendiola C
    Cancer Treat Rep; 1979 May; 63(5):903-8. PubMed ID: 455331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quelamycin: a summary of phase I clinical trials.
    Cortés-Funes H; Brugarolas A; Gosálvez M
    Recent Results Cancer Res; 1980; 74():200-6. PubMed ID: 7444140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical strategy for evaluation of anthracycline analogues.
    Benjamin RS
    Recent Results Cancer Res; 1980; 70():67-73. PubMed ID: 7355252
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary phase I study of 4'-epi-adriamycin.
    Bonfante V; Bonadonna G; Villani F; Di Fronzo G; Martini A; Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):915-8. PubMed ID: 455333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical study of quelamycin.
    Brugarolas A; Pachon N; Gosalvez M; Llanderal AP; Lacave AJ; Buesa JM; Marco MG
    Cancer Treat Rep; 1978 Oct; 62(10):1527-34. PubMed ID: 361226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirarubicin in advanced breast cancer: a French cooperative phase II study.
    Spielmann M; Kerbrat P; Delozier T; Fumoleau P; Monnier A; Chevallier B; Bastit P; Namer M; Cattan A; Lucas P
    Eur J Cancer; 1990; 26(7):821-3. PubMed ID: 2145903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THP-adriamycin: status of the clinical development of a new anthracycline in France].
    Herait P
    Pathol Biol (Paris); 1990 Jan; 38(1):64-8. PubMed ID: 2308782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK; Wittes RE; Gralla RJ; Casper ES; Young CW
    Cancer Clin Trials; 1981; 4(4):433-7. PubMed ID: 7318126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron toxicity studies of quelamycin.
    Brugarolas A; Perez Llanderal JA; Garcia Miralles MT; Lacave AJ; Gracia Marco M; Izquierdo JM; Rodriguez Llorian AC; Ribas A
    Cancer Treat Rep; 1979 May; 63(5):909-13. PubMed ID: 455332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity of quelamycin in the rat.
    Jortner BS; Cho ES
    Neurotoxicology; 1981 Dec; 2(4):789-92. PubMed ID: 7200587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32.
    Blum RH; Garnick MB; Israel M; Panellos GP; Henderson IC; Frei E
    Recent Results Cancer Res; 1981; 76():7-15. PubMed ID: 7232854
    [No Abstract]   [Full Text] [Related]  

  • 15. 1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
    Lokich JJ; Skarin AT; Frei E
    Cancer; 1974 Nov; 34(5):1593-7. PubMed ID: 4426026
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary evaluation of myocardial toxicity of 4'-deoxydoxorubicin: experimental and clinical results.
    Villani F; Comazzi R; Genitoni V; Lacaita G; Guindani A; Crippa F; Monti E; Piccinini F; Rozza A; Lanza E
    Drugs Exp Clin Res; 1985; 11(3):223-31. PubMed ID: 3836127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin (Adriamycin)--a new anticancer drug.
    Med Lett Drugs Ther; 1975 May; 17(10):42-3. PubMed ID: 1055286
    [No Abstract]   [Full Text] [Related]  

  • 18. Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study.
    Jehn CF; Hemmati P; Lehenbauer-Dehm S; Kümmel S; Flath B; Schmid P
    Clin Breast Cancer; 2016 Dec; 16(6):514-519. PubMed ID: 27395417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.
    Dantchev D; Paintrand M; Hayat M; Bourut C; Mathé G
    J Antibiot (Tokyo); 1979 Oct; 32(10):1085-6. PubMed ID: 528374
    [No Abstract]   [Full Text] [Related]  

  • 20. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer].
    Takeda C
    Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.